All Stories

  1. Alterations in epigenetic marks and expression of genes related to stress regulation: an exploratory study among newborns after fetal repair of spina bifida aperta

    Article • Epigenetics, March 2026, Taylor & Francis

    Dr Edna Grünblatt

  2. Are There Causal Associations Between Obsessive‐Compulsive Disorder and Cardiometabolic Phenotypes? A Genetic Correlation and Bi‐Directional Mendelian Randomization Study

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, January 2026, Wiley

    Dr Edna Grünblatt

  3. ω-3 Fatty Acids in Pediatric Major Depressive Disorder

    Article • JAMA Network Open, January 2026, American Medical Association (AMA)

    Dr Edna Grünblatt

  4. Mapping the genetic landscape across 14 psychiatric disorders

    Article • Nature, December 2025, Springer Science + Business Media

    Fernando Fernandez-Aranda, Dr Edna Grünblatt

  5. Peer victimization in adolescence alters gene expression and cytokine profiles during transition to adulthood

    Article • Brain Behavior & Immunity - Health, October 2025, Elsevier

    Dr Edna Grünblatt

  6. The role of astrocytes in attention-deficit hyperactivity disorder: An update

    Article • Psychiatry Research, August 2025, Elsevier

    Dr Edna Grünblatt

  7. Assessing the effects of methylphenidate in proliferation and Wnt activity of neuronal stem cells from attention deficit/hyperactivity disorder patients

    Article • Acta Neurovegetativa, July 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  8. Polygenic Hazard Score for Predicting Age-associated Risk of Alzheimer’s Disease in European Populations: Development and Validation

    Article • July 2025, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  9. Machine learning in Alzheimer’s disease genetics

    Article • Nature Communications, July 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  10. The link between Wnt-related, stress-related, and circadian genes in the dermal fibroblasts of individuals with attention-deficit hyperactivity disorder

    Article • Acta Neurovegetativa, July 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  11. Approaching therapy of Alzheimer’s disease via the antidiabetic drug liraglutide—a study with streptozotocin intracerebroventricularly treated Wistar rats

    Article • Acta Neurovegetativa, July 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  12. Thiamine Compounds Alleviate Oxidative Stress, Over-Expression of Pro-Inflammatory Markers and Behavioral Abnormalities in a Mouse Predation Model of PTSD

    Article • International Journal of Molecular Sciences, July 2025, MDPI AG

    Dr Edna Grünblatt

  13. Ensemblex: an accuracy-weighted ensemble genetic demultiplexing framework for population-scale scRNAseq sample pooling

    Article • Genome Biology, July 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  14. From stress to anhedonia: differential gene expression, behavioural and biochemical modulations in resilient versus susceptible mice in an ultrasound model of juvenile depression

    Article • Acta Neurovegetativa, July 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  15. Transferability of European-derived Alzheimer’s disease polygenic risk scores across multiancestry populations

    Article • Nature Genetics, June 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  16. Genome-wide analyses identify 30 loci associated with obsessive–compulsive disorder

    Article • Nature Genetics, May 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  17. APOEstratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimers’s disease

    Article • May 2025, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  18. Genetic susceptibility to schizophrenia through neuroinflammatory pathways associated with retinal thinness

    Article • Nature Mental Health, April 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  19. Neurodevelopmental effects of omega-3 fatty acids and its combination with Methylphenidate in iPSC models of ADHD

    Article • Journal of Psychiatric Research, April 2025, Elsevier

    Dr Edna Grünblatt

  20. Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre‐Administration in a Randomized, Double‐Blind, Cross‐Over Phase I Trial

    Article • Clinical Pharmacology & Therapeutics, February 2025, Wiley

    Dr Edna Grünblatt

  21. Alterations in proliferation of neuronal stem cells in Attention-Deficit/Hyperactivity Disorder and Wnt modulation by methylphenidate

    Article • February 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  22. Exploring the interplay of glucose metabolism, insulin resistance, and neurodegenerative pathologies: insights from streptozotocin and hypoglycaemic in vitro models

    Article • Acta Neurovegetativa, February 2025, Springer Science + Business Media

    Dr Edna Grünblatt

  23. Investigating the impact of omega-3 fatty acids on oxidative stress and pro-inflammatory cytokine release in iPSC-derived forebrain cortical neurons from ADHD patients

    Article • Journal of Psychiatric Research, February 2025, Elsevier

    Dr Edna Grünblatt

  24. X‐chromosome-wide association study for Alzheimer’s disease

    Article • Molecular Psychiatry, December 2024, Springer Science + Business Media

    Dr Edna Grünblatt

  25. Generation of induced pluripotent stem cells from ADHD patients who do or do not respond to Methylphenidate treatment

    Article • Stem Cell Research, December 2024, Elsevier

    Dr Edna Grünblatt

  26. Extremely rare CNVs contributing to Alzheimer disease risk: a case-control association analysis of exome sequencing data from 22,319 individuals

    Article • November 2024, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  27. Peer victimization in adolescence alters gene expression and cytokine profiles during transition to adulthood

    Article • July 2024, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  28. A genome‐wide association meta‐analysis of all‐cause and vascular dementia

    Article • Alzheimer s & Dementia, July 2024, Wiley

    Dr Edna Grünblatt

  29. Ensemblex: an accuracy-weighted ensemble genetic demultiplexing framework for population-scale scRNAseq sample pooling

    Article • July 2024, Springer Science + Business Media

    Dr Edna Grünblatt

  30. Ensemblex: an accuracy-weighted ensemble genetic demultiplexing framework for population-scale scRNAseq sample pooling

    Article • June 2024, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  31. Correspondence to “Bipolar disorder-iPSC derived neural progenitor cells exhibit dysregulation of store-operated Ca2+ entry and accelerated differentiation” by Hewitt et al. (PMID: 37402854)

    Article • Molecular Psychiatry, May 2024, Springer Science + Business Media

    Dr Edna Grünblatt

  32. Long non-coding RNAs H19 and NKILA are associated with the risk of death and lacunar stroke in the elderly population

    Article • European Journal of Internal Medicine, May 2024, Elsevier

    Dr Edna Grünblatt

  33. Genetic susceptibility to schizophrenia through neuroinflammatory pathways is associated with retinal thinning: Findings from the UK-Biobank

    Article • April 2024, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  34. Stress as a mediator of brain alterations in attention-deficit hyperactivity disorder: A systematic review

    Article • Comprehensive Psychiatry, April 2024, Elsevier

    Dr Edna Grünblatt

  35. Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder

    Article • March 2024, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  36. Correction: White matter diffusion estimates in obsessive-compulsive disorder across 1653 individuals: machine learning findings from the ENIGMA OCD Working Group

    Article • Molecular Psychiatry, March 2024, Springer Science + Business Media

    Dr Edna Grünblatt

  37. White matter diffusion estimates in obsessive-compulsive disorder across 1653 individuals: machine learning findings from the ENIGMA OCD Working Group

    Article • Molecular Psychiatry, February 2024, Springer Science + Business Media

    Dr Edna Grünblatt

  38. Psychopharmacology in children and adolescents: unmet needs and opportunities

    Article • The Lancet Psychiatry, February 2024, Elsevier

    Dr Edna Grünblatt

  39. Iron status in Swiss adolescents with paediatric major depressive disorder and healthy controls: a matched case–control study

    Article • Zeitschrift für Ernährungswissenschaft, January 2024, Springer Science + Business Media

    Dr Edna Grünblatt

  40. Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms

    Article • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, January 2024, Wiley

    Dr Edna Grünblatt

  41. An investigation on the alterations in Wnt signaling in ADHD across developmental stages

    Article • Neuroscience Applied, January 2024, Elsevier

    Dr Edna Grünblatt

  42. Is there an intrinsic link between attention-deficit/hyperactivity disorder and Alzheimer's disease? Examination using polygenic risk scores in the UK Biobank

    Article • Neuroscience Applied, January 2024, Elsevier

    Dr Edna Grünblatt

  43. Transferability of European-derived Alzheimer’s Disease Polygenic Risk Scores across Multi-Ancestry Populations

    Article • October 2023, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  44. Editorial: Obsessive-compulsive related disorders (OCRD) across the lifespan

    Article • Frontiers in Psychiatry, October 2023, Frontiers

    Dr Edna Grünblatt

  45. Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

    Article • Proceedings of the National Academy of Sciences, August 2023, Proceedings of the National Academy of Sciences

    Dr Edna Grünblatt

  46. Executive functions and borderline personality features in adolescents with major depressive disorder

    Article • Frontiers in Human Neuroscience, June 2023, Frontiers

    Dr Edna Grünblatt

  47. The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications

    Article • Neuroscience & Biobehavioral Reviews, June 2023, Elsevier

    Associate professor Mikkel Højlund, Dr Edna Grünblatt, Dejan Stevanovic

  48. Generation of induced pluripotent stem cells from two ADHD patients and two healthy controls

    Article • Stem Cell Research, June 2023, Elsevier

    Dr Edna Grünblatt

  49. Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

    Article • JAMA Network Open, May 2023, American Medical Association (AMA)

    Dr Edna Grünblatt

  50. Circulating Long Noncoding RNA Signatures Associate With Incident Diabetes in Older Adults: A Prospective Analysis From the VITA Cohort Study

    Article • Diabetes Care, April 2023, American Diabetes Association

    Dr Edna Grünblatt

  51. Circulating long noncoding RNA signatures associate with incident diabetes in older adults: a prospective analysis from the VITA cohort study

    Article • April 2023, American Diabetes Association

    Dr Edna Grünblatt

  52. Circulating long noncoding RNA signatures associate with incident diabetes in older adults: a prospective analysis from the VITA cohort study

    Article • April 2023, American Diabetes Association

    Dr Edna Grünblatt

  53. Growth rates of human induced pluripotent stem cells and neural stem cells from attention-deficit hyperactivity disorder patients: a preliminary study

    Article • Acta Neurovegetativa, February 2023, Springer Science + Business Media

    Dr Edna Grünblatt

  54. From attention-deficit hyperactivity disorder to sporadic Alzheimer’s disease—Wnt/mTOR pathways hypothesis

    Article • Frontiers in Neuroscience, February 2023, Frontiers

    Dr Edna Grünblatt

  55. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

    Article • Nature Communications, February 2023, Springer Science + Business Media

    Dr Edna Grünblatt

  56. Elucidating the functional effects of omega-3 fatty acids as a treatment in ADHD against inflammation and oxidative stress

    Article • Neuroscience Applied, January 2023, Elsevier

    Dr Edna Grünblatt

  57. Involvement of the WNT signalling in methylphenidate (ritalin) treatment of attention deficit hyperactivity disorder

    Article • Neuroscience Applied, January 2023, Elsevier

    Dr Edna Grünblatt

  58. Protocol for a Wnt reporter assay to measure its activity in human neural stem cells derived from induced pluripotent stem cells

    Article • Current Research in Neurobiology, January 2023, Elsevier

    Dr Edna Grünblatt

  59. Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders

    Article • Neuroscience Applied, January 2023, Elsevier

    Dr Edna Grünblatt

  60. Advances in problematic usage of the internet research – A narrative review by experts from the European network for problematic usage of the internet

    Article • Comprehensive Psychiatry, October 2022, Elsevier

    Dr Edna Grünblatt

  61. A review of the genetic basis of problematic Internet use

    Article • Current Opinion in Behavioral Sciences, August 2022, Elsevier

    Dr Edna Grünblatt

  62. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease

    Article • JAMA Neurology, July 2022, American Medical Association (AMA)

    Dr Edna Grünblatt

  63. Protective association of HLA-DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences

    Article • May 2022, Springer Science + Business Media

    Dr Edna Grünblatt

  64. Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage

    Article • Acta Neurovegetativa, April 2022, Springer Science + Business Media

    Dr Edna Grünblatt

  65. New insights into the genetic etiology of Alzheimer’s disease and related dementias

    Article • Nature Genetics, April 2022, Springer Science + Business Media

    Dr Edna Grünblatt, Jari Lahti

  66. Media use and emotional distress under COVID-19 lockdown in a clinical sample referred for internalizing disorders: A Swiss adolescents' perspective

    Article • Journal of Psychiatric Research, March 2022, Elsevier

    Dr Edna Grünblatt

  67. Problematic use of the internet during the COVID-19 pandemic: Good practices and mental health recommendations

    Article • Comprehensive Psychiatry, January 2022, Elsevier

    Dr Edna Grünblatt

  68. Promising Developments in the Use of Induced Pluripotent Stem Cells in Research of ADHD

    Article • January 2022, Springer Science + Business Media

    Dr Edna Grünblatt

  69. Elucidating the functional effects of omega-3 fatty acids as a treatment in ADHD against Wnt-signalling alterations

    Article • Neuroscience Applied, January 2022, Elsevier

    Dr Edna Grünblatt

  70. Protective association of HLA-DRB1*04 subtypes in neurodegenerative diseases implicates acetylated Tau PHF6 sequences

    Article • December 2021, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  71. P.0006 BDNF levels in blood serum and plasma of MDMA users and MDMA-naïve controls

    Article • European Neuropsychopharmacology, December 2021, Elsevier

    Dr Edna Grünblatt

  72. P.0025 Preliminary results of growth rate profiling of induced pluripotent stem cells and neuronal progenitor cells from Attention-Deficit Hyperactivity Disorder

    Article • European Neuropsychopharmacology, December 2021, Elsevier

    Dr Edna Grünblatt

  73. Polygenic risk scores across the extended psychosis spectrum

    Article • Translational Psychiatry, November 2021, Springer Science + Business Media

    Dr Edna Grünblatt

  74. Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects

    Article • Clinical Pharmacology & Therapeutics, November 2021, Wiley

    Dr Edna Grünblatt

  75. Genome-wide association study identifies new locus associated with OCD

    Article • October 2021, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  76. Media use before, during and after COVID-19 lockdown according to parents in a clinically referred sample in child and adolescent psychiatry: Results of an online survey in Switzerland

    Article • Comprehensive Psychiatry, August 2021, Elsevier

    Dr Edna Grünblatt

  77. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

    Article • Nature Communications, June 2021, Springer Science + Business Media

    Dr Edna Grünblatt

  78. Generation of integration-free induced pluripotent stem cell lines from four pediatric ADHD patients

    Article • Stem Cell Research, May 2021, Elsevier

    Dr Edna Grünblatt

  79. Generation of integration-free induced pluripotent stem cells from healthy individuals

    Article • Stem Cell Research, May 2021, Elsevier

    Dr Edna Grünblatt

  80. The Interplay Between Postsynaptic Striatal D2/3 Receptor Availability, Adversity Exposure and Odd Beliefs: A [11C]-Raclopride PET Study

    Article • Schizophrenia Bulletin, April 2021, Oxford University Press (OUP)

    Dr Edna Grünblatt

  81. Genome-wide association study of pediatric obsessive-compulsive traits: shared genetic risk between traits and disorder

    Article • Translational Psychiatry, February 2021, Springer Science + Business Media

    Elizabeth C Corfield, Dr Edna Grünblatt

  82. Genetics of OCD and Related Disorders; Searching for Shared Factors

    Article • January 2021, Springer Science + Business Media

    Dr Edna Grünblatt

  83. New insights on the genetic etiology of Alzheimer’s and related dementia

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  84. The stress–Wnt-signaling axis: a hypothesis for attention-deficit hyperactivity disorder and therapy approaches

    Article • Translational Psychiatry, September 2020, Springer Science + Business Media

    Dr Edna Grünblatt

  85. Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance

    Article • Comprehensive Psychiatry, July 2020, Elsevier

    Dr Edna Grünblatt

  86. ADHD: Current Concepts and Treatments in Children and Adolescents

    Article • Neuropediatrics, June 2020, Thieme Publishing Group

    Dr Edna Grünblatt

  87. Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders

    Article • International Clinical Psychopharmacology, May 2020, Wolters Kluwer Health

    Dr Edna Grünblatt

  88. An overview of the first 5 years of the ENIGMA obsessive–compulsive disorder working group: The power of worldwide collaboration

    Article • Human Brain Mapping, March 2020, Wiley

    Dr Edna Grünblatt, Pedro Morgado

  89. Psychiatric symptoms and expression of glucocorticoid receptor gene in cocaine users: A longitudinal study

    Article • Journal of Psychiatric Research, February 2020, Elsevier

    Dr Edna Grünblatt

  90. Profiling parvalbumin interneurons using iPSC: challenges and perspectives for Autism Spectrum Disorder (ASD)

    Article • Molecular Autism, January 2020, Springer Science + Business Media

    Dr Edna Grünblatt

  91. Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings

    Article • Molecular Psychiatry, January 2020, Springer Science + Business Media

    Dr Edna Grünblatt

  92. Genetics of obsessive-compulsive disorder and Tourette disorder

    Article • January 2020, Elsevier

    Dr Edna Grünblatt

  93. High-resolution chromosomal microarray analysis for copy-number variations in high-functioning autism reveals large aberration typical for intellectual disability

    Article • Acta Neurovegetativa, December 2019, Springer Science + Business Media

    Dr Edna Grünblatt

  94. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

    Article • Cell, December 2019, Elsevier

    Dr Edna Grünblatt, Assistant Professor Hunna J Watson, Professor, Director Gunnar Morken, Fernando Fernandez-Aranda, Associate Professor Jennifer Jordan, MD Michael S Okun

  95. Genome-wide Association Study of Pediatric Obsessive-Compulsive Traits: Shared Genetic Risk between Traits and Disorder

    Article • November 2019, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt, Elizabeth C Corfield

  96. Omega-3 Fatty Acids as a Treatment for Pediatric Depression. A Phase III, 36 Weeks, Multi-Center, Double-Blind, Placebo-Controlled Randomized Superiority Study

    Article • Frontiers in Psychiatry, November 2019, Frontiers

    Dr Edna Grünblatt

  97. Rare copy number variants in individuals at clinical high risk for psychosis: Enrichment of synaptic/brain‐related functional pathways

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, November 2019, Wiley

    Dr Edna Grünblatt

  98. Common variants in Alzheimer's disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores

    Article • November 2019, Cold Spring Harbor Laboratory Press

    Dr Edna Grünblatt

  99. Influence of oxytocin receptor single nucleotide sequence variants on contractility of human myometrium: an in vitro functional study

    Article • BMC Medical Genetics, November 2019, Springer Science + Business Media

    Dr Edna Grünblatt

  100. New insights and perspectives on the genetics of obsessive-compulsive disorder

    Article • Psychiatric Genetics, October 2019, Wolters Kluwer Health

    Dr Edna Grünblatt

  101. No Association of Variants of the NPY-System With Obsessive-Compulsive Disorder in Children and Adolescents

    Article • Frontiers in Molecular Neuroscience, May 2019, Frontiers

    Dr Edna Grünblatt

  102. Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice

    Article • Neuropharmacology, April 2019, Elsevier

    Dr Edna Grünblatt

  103. Association study and a systematic meta-analysis of the VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder

    Article • Acta Neurovegetativa, March 2019, Springer Science + Business Media

    Dr Edna Grünblatt

  104. Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity – a consensus of the Biomarkers Task Force from the WFSBP

    Article • The World Journal of Biological Psychiatry, March 2019, Taylor & Francis

    Dr Edna Grünblatt, Dr Brisa Fernandes, Kamyar Keramatian

  105. Astrocyte- and Microglia-Specific Mitochondrial DNA Deletions Levels in Sporadic Alzheimer’s Disease

    Article • Journal of Alzheimer’s Disease, January 2019, IOS Press

    Dr Edna Grünblatt

  106. The involvement of the canonical Wnt-signaling receptor LRP5 and LRP6 gene variants with ADHD and sexual dimorphism: Association study and meta-analysis

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, November 2018, Wiley

    Dr Edna Grünblatt, Dr. Hauke Thomsen

  107. Manifesto for a European research network into Problematic Usage of the Internet

    Article • European Neuropsychopharmacology, October 2018, Elsevier

    Dr Edna Grünblatt

  108. Improved Generation of Induced Pluripotent Stem Cells From Hair Derived Keratinocytes – A Tool to Study Neurodevelopmental Disorders as ADHD

    Article • Frontiers in Cellular Neuroscience, September 2018, Frontiers

    Dr Edna Grünblatt

  109. Comment on the global gaming industry's statement on ICD-11 gaming disorder: a corporate strategy to disregard harm and deflect social responsibility?

    Article • Addiction, August 2018, Wiley

    Dr Edna Grünblatt, Joseph Macey

  110. Glucocorticoid receptor gene variants and lower expression of NR3C1 are associated with cocaine use

    Article • Addiction Biology, May 2018, Wiley

    Dr Edna Grünblatt

  111. Neuregulin 1 (NRG1) gene expression predicts functional outcomes in individuals at clinical high-risk for psychosis

    Article • Psychiatry Research, May 2018, Elsevier

    Dr Edna Grünblatt

  112. Methylphenidate enhances neuronal differentiation and reduces proliferation concomitant to activation of Wnt signal transduction pathways

    Article • Translational Psychiatry, March 2018, Nature

    Dr Edna Grünblatt

  113. Neurochemical markers as potential indicators of postmortem tissue quality

    Article • January 2018, Elsevier

    Dr Edna Grünblatt

  114. Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of DAO, DAOA, and NRG1 Variants with Negative Symptoms and Cognitive Deficits

    Article • Frontiers in Psychiatry, December 2017, Frontiers

    Dr Edna Grünblatt

  115. Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson’s Disease Substantia Nigra

    Article • Neurotoxicity Research, December 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  116. A pilot investigation on DNA methylation modifications associated with complex posttraumatic symptoms in elderly traumatized in childhood

    Article • BMC Research Notes, December 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  117. High resolution chromosomal microarray analysis in paediatric obsessive-compulsive disorder

    Article • BMC Medical Genomics, November 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  118. Controversial Effects of D-Amino Acid Oxidase Activator (DAOA)/G72 on D-Amino Acid Oxidase (DAO) Activity in Human Neuronal, Astrocyte and Kidney Cell Lines: The N-methyl D-aspartate (NMDA) Receptor Hypofunction Point of View

    Article • Frontiers in Molecular Neuroscience, October 2017, Frontiers

    Dr Edna Grünblatt

  119. Integrating evolutionary and regulatory information with a multispecies approach implicates genes and pathways in obsessive-compulsive disorder

    Article • Nature Communications, October 2017, Nature

    Dr Edna Grünblatt

  120. Explorative results from multistep screening for potential genetic risk loci of Alzheimer’s disease in the longitudinal VITA study cohort

    Article • Acta Neurovegetativa, October 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  121. The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, October 2017, Elsevier

    Dr Edna Grünblatt

  122. Combining genetic and epigenetic parameters of the serotonin transporter gene in obsessive-compulsive disorder

    Article • Journal of Psychiatric Research, October 2017, Elsevier

    Dr Edna Grünblatt

  123. A systematic meta-analysis of the association of Neuregulin 1 (NRG1), d-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia

    Article • Acta Neurovegetativa, September 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  124. Effects of oxytocin and arginine vasopressin on the proliferation and differentiation of a serotonergic cell line

    Article • Acta Neurovegetativa, August 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  125. The diabetic brain and cognition

    Article • Acta Neurovegetativa, August 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  126. Revealing the complex genetic architecture of obsessive–compulsive disorder using meta-analysis

    Article • Molecular Psychiatry, August 2017, Nature

    Dr Edna Grünblatt

  127. Determination of Monoamine Oxidase A and B Activity in Long-Term Treated Patients With Parkinson Disease

    Article • Clinical Neuropharmacology, July 2017, Wolters Kluwer Health

    Dr Edna Grünblatt

  128. A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects

    Article • Frontiers in Pharmacology, June 2017, Frontiers

    Dr Edna Grünblatt

  129. Emerging role of miRNA in attention deficit hyperactivity disorder: a systematic review

    Article • ADHD Attention Deficit and Hyperactivity Disorders, May 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  130. Expression of D-Amino Acid Oxidase (DAO/DAAO) and D-Amino Acid Oxidase Activator (DAOA/G72) during Development and Aging in the Human Post-mortem Brain

    Article • Frontiers in Neuroanatomy, April 2017, Frontiers

    Dr Edna Grünblatt

  131. The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension

    Article • Acta Neurovegetativa, March 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  132. Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson’s disease

    Article • Acta Neurovegetativa, March 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  133. Neuregulin-1, D-amino acid oxidase and D-amino acid oxidase activator polymorphisms in individuals at-risk for psychosis

    Article • European Neuropsychopharmacology, March 2017, Elsevier

    Dr Edna Grünblatt

  134. DNA methylation profiles of elderly individuals subjected to indentured childhood labor and trauma

    Article • BMC Medical Genetics, February 2017, Springer Science + Business Media

    Dr Edna Grünblatt

  135. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms

    Article • The World Journal of Biological Psychiatry, October 2016, Taylor & Francis

    Dr Edna Grünblatt

  136. Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

    Article • The World Journal of Biological Psychiatry, July 2016, Taylor & Francis

    Dr Edna Grünblatt

  137. Biological markers for anxiety disorders, OCD and PTSD – a consensus statement. Part I: Neuroimaging and genetics

    Article • The World Journal of Biological Psychiatry, July 2016, Taylor & Francis

    Dr Edna Grünblatt

  138. REGION-SPECIFIC REGULATION OF THE SEROTONIN 2A RECEPTOR EXPRESSION IN DEVELOPMENT AND AGING IN POSTMORTEM HUMAN BRAIN

    Article • European Neuropsychopharmacology, May 2016, Elsevier

    Dr Edna Grünblatt

  139. CNTNAP2 gene in high functioning autism: no association according to family and meta-analysis approaches

    Article • Acta Neurovegetativa, November 2015, Springer Science + Business Media

    Dr Edna Grünblatt

  140. α2A -Adrenergic receptor polymorphisms and mRNA expression levels are associated with delay discounting in cocaine users

    Article • Addiction Biology, November 2015, Wiley

    Dr Edna Grünblatt

  141. Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction

    Article • Journal of Molecular Psychiatry, June 2015, Springer Science + Business Media

    Dr Edna Grünblatt

  142. Serotonin Transporter and Tryptophan Hydroxylase Gene Variations Mediate Working Memory Deficits of Cocaine Users

    Article • Neuropsychopharmacology, May 2015, Nature

    Dr Edna Grünblatt

  143. Region-specific regulation of the serotonin 2A receptor expression in development and ageing inpost mortemhuman brain

    Article • Neuropathology and Applied Neurobiology, May 2015, Wiley

    Dr Edna Grünblatt

  144. Was können Biomarker heute leisten? Über den Einsatz von Biomarkern in der psychiatrischen Diagnostik am Beispiel der ADHS

    Article • PSYCH up2date, March 2015, Thieme Publishing Group

    Dr Edna Grünblatt

  145. Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer’s disease progression: CX3CL1, TREM2, and PPARγ

    Article • Acta Neurovegetativa, January 2015, Springer Science + Business Media

    Dr Edna Grünblatt

  146. Cross-Disorder Genome-Wide Analyses Suggest a Complex Genetic Relationship Between Tourette’s Syndrome and OCD

    Article • American Journal of Psychiatry, January 2015, American Psychiatric Association

    Dr Edna Grünblatt, Yehuda Pollak

  147. Neurotrophin blood-based gene expression and social cognition analysis in patients with autism spectrum disorder

    Article • Neurogenetics, December 2014, Springer Science + Business Media

    Dr Edna Grünblatt

  148. Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer’s disease

    Article • Acta Neurovegetativa, December 2014, Springer Science + Business Media

    Dr Edna Grünblatt

  149. Was sind Omics?

    Article • PSYCH up2date, November 2014, Thieme Publishing Group

    Dr Edna Grünblatt

  150. Prenatal stress increases the striatal and hippocampal expression of correlating c-FOS and serotonin transporters in murine offspring

    Article • International Journal of Developmental Neuroscience, November 2014, Elsevier

    Dr Edna Grünblatt

  151. Aldehyde dehydrogenase (ALDH) in Alzheimer’s and Parkinson’s disease

    Article • Acta Neurovegetativa, October 2014, Springer Science + Business Media

    Dr Edna Grünblatt

  152. Imaging genetics in obsessive-compulsive disorder: Linking genetic variations to alterations in neuroimaging

    Article • Progress in Neurobiology, October 2014, Elsevier

    Dr Edna Grünblatt

  153. P.1.g.071 Interaction between serotonin 1A and 2A receptor subtypes in neuronal and lymphoblastoid cells

    Article • European Neuropsychopharmacology, October 2014, Elsevier

    Dr Edna Grünblatt

  154. Trio study and meta-analysis support the association of genetic variation at the serotonin transporter with early-onset obsessive–compulsive disorder

    Article • Neuroscience Letters, September 2014, Elsevier

    Dr Edna Grünblatt

  155. Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study

    Article • Acta Neurovegetativa, August 2014, Springer Science + Business Media

    Dr Edna Grünblatt

  156. Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

    Article • Journal of Visualized Experiments, August 2014, MyJove Corporation

    Dr Edna Grünblatt

  157. Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

    Article • Journal of Visualized Experiments, August 2014, MyJove Corporation

    Dr Edna Grünblatt

  158. Copy Number Variation in Obsessive-Compulsive Disorder and Tourette Syndrome: A Cross-Disorder Study

    Article • Journal of the American Academy of Child & Adolescent Psychiatry, August 2014, Elsevier

    Dr Edna Grünblatt, Yehuda Pollak

  159. The neurobiological link between OCD and ADHD

    Article • ADHD Attention Deficit and Hyperactivity Disorders, July 2014, Springer Science + Business Media

    Dr Edna Grünblatt

  160. Wie biologisch sind Zwangsstörungen?

    Article • Kindheit und Entwicklung, April 2014, Hogrefe Publishing Group

    Dr Edna Grünblatt

  161. Neuron-Specific Alterations in Signal Transduction Pathways associated with Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, March 2014, IOS Press

    Dr Edna Grünblatt

  162. Extraordinarily Fast Response to Low-Dose Sertraline in a Child with Severe Obsessive-Compulsive Disorder and High Functioning Serotonin Transporter Genotype

    Article • Journal of Child and Adolescent Psychopharmacology, March 2014, Mary Ann Liebert Inc

    Dr Edna Grünblatt

  163. Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder

    Article • Acta Neurovegetativa, February 2014, Springer Science + Business Media

    Dr Edna Grünblatt

  164. Investigation of association of serotonin transporter and monoamine oxidase-A genes with Alzheimer's disease and depression in the VITA study cohort: A 90-month longitudinal study

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, January 2014, Wiley

    Dr Edna Grünblatt

  165. Aldehyde dehydrogenase 2 in sporadic Parkinson's disease

    Article • Parkinsonism & Related Disorders, January 2014, Elsevier

    Dr Edna Grünblatt

  166. Association study in siblings and case-controls of serotonin- and oxytocin-related genes with high functioning autism

    Article • Journal of Molecular Psychiatry, January 2014, Springer Science + Business Media

    Dr Edna Grünblatt

  167. Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene

    Article • Molecular Autism, January 2014, Springer Science + Business Media

    Dr Edna Grünblatt

  168. Enhancement of cell viability after treatment with polyunsaturated fatty acids

    Article • Neuroscience Letters, January 2014, Elsevier

    Dr Edna Grünblatt

  169. Neuron-Specific Mitochondrial DNA Deletion Levels in Sporadic Alzheimer´s Disease

    Article • Current Alzheimer Research, December 2013, Bentham Science Publishers

    Dr Edna Grünblatt

  170. Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity

    Article • Acta Neurovegetativa, November 2013, Springer Science + Business Media

    Dr Edna Grünblatt

  171. The Loudness Dependence of Auditory Evoked Potentials (LDAEP) as an Indicator of Serotonergic Dysfunction in Patients with Predominant Schizophrenic Negative Symptoms

    Article • PLOS One, July 2013, PLOS

    Dr Edna Grünblatt

  172. 5-HT2A serotonin receptor agonist DOI alleviates cytotoxicity in neuroblastoma cells: Role of the ERK pathway

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, July 2013, Elsevier

    Dr Edna Grünblatt

  173. Manifesto for a European research network into obsessive-compulsive and related disorders

    Article • European Neuropsychopharmacology, July 2013, Elsevier

    Dr Edna Grünblatt

  174. Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?

    Article • ADHD Attention Deficit and Hyperactivity Disorders, April 2013, Springer Science + Business Media

    Dr Edna Grünblatt

  175. Correction: Methylphenidate enhances neural stem cell differentiation

    Article • Journal of Molecular Psychiatry, January 2013, Springer Science + Business Media

    Dr Edna Grünblatt

  176. Methylphenidate enhances neural stem cell differentiation

    Article • Journal of Molecular Psychiatry, January 2013, Springer Science + Business Media

    Dr Edna Grünblatt

  177. S.08.03 New findings of copy number variations in OCD

    Article • European Neuropsychopharmacology, October 2012, Elsevier

    Dr Edna Grünblatt

  178. S.08.01 Potential biomarkers and genetic findings in ADHD

    Article • European Neuropsychopharmacology, October 2012, Elsevier

    Dr Edna Grünblatt

  179. Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study

    Article • Acta Neuropathologica, August 2012, Springer Science + Business Media

    Dr Edna Grünblatt, Professor Piero Parchi

  180. In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder

    Article • Acta Neurovegetativa, July 2012, Springer Science + Business Media

    Dr Edna Grünblatt

  181. Editorial

    Article • Acta Neurovegetativa, July 2012, Springer Science + Business Media

    Dr Edna Grünblatt

  182. Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways

    Article • Acta Neurovegetativa, July 2012, Springer Science + Business Media

    Dr Edna Grünblatt

  183. Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole blood

    Article • ADHD Attention Deficit and Hyperactivity Disorders, May 2012, Springer Science + Business Media

    Dr Edna Grünblatt

  184. Alzheimer's disease and type 2 diabetes: Two diseases, one common link?

    Article • The World Journal of Biological Psychiatry, February 2012, Taylor & Francis

    Dr Edna Grünblatt

  185. Parkinson's disease: Molecular risk factors

    Article • Parkinsonism & Related Disorders, January 2012, Elsevier

    Dr Edna Grünblatt

  186. Inflammatory Pathways in Parkinson’s Disease; A BNE Microarray Study

    Article • Parkinson s Disease, January 2012, Hindawi Publishing Corporation

    Dr Edna Grünblatt

  187. A molecular signature in blood identifies early Parkinson’s disease

    Article • Molecular Neurodegeneration, January 2012, Springer Science + Business Media

    Dr Edna Grünblatt

  188. 1.12.1 PARKINSON'S DISEASE: MOLECULAR RISK FACTORS

    Article • Parkinsonism & Related Disorders, January 2012, Elsevier

    Dr Edna Grünblatt

  189. Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzymegene

    Article • BMC Medical Genetics, November 2011, Springer Science + Business Media

    Dr Edna Grünblatt

  190. Altered mRNA expression of monoaminergic candidate genes in the blood of children with attention deficit hyperactivity disorder and autism spectrum disorder

    Article • The World Journal of Biological Psychiatry, September 2011, Taylor & Francis

    Dr Edna Grünblatt

  191. Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer’s disease: The VITA and Milano studies

    Article • Journal of Psychiatric Research, September 2011, Elsevier

    Dr Edna Grünblatt

  192. d/l threo-methylphenidate enantiomers influence on catecholaminergic enzyme activities

    Article • Pharmacopsychiatry, September 2011, Thieme Publishing Group

    Dr Edna Grünblatt

  193. Pilot study on HTR2A promoter polymorphism, −1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive–compulsive disorder

    Article • Acta Neurovegetativa, August 2011, Springer Science + Business Media

    Dr Edna Grünblatt

  194. Correlation of cognitive deficits and brain cholinesterase activity in streptozotocin-intracerebroventricularly treated rat model of sporadic alzheimer's disease

    Article • Alzheimer s & Dementia, July 2011, Elsevier

    Dr Edna Grünblatt

  195. Editorial

    Article • Acta Neurovegetativa, March 2011, Springer Science + Business Media

    Dr Edna Grünblatt

  196. Association of a Functional NOS1 Promoter Repeat with Alzheimer's Disease in the VITA Cohort

    Article • Journal of Alzheimer’s Disease, February 2011, IOS Press

    Dr Edna Grünblatt

  197. Transcriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats

    Article • Acta Neurovegetativa, December 2010, Springer Science + Business Media

    Dr Edna Grünblatt

  198. Brain tryptophan rather than pH-value is altered as consequence of artificial postmortem interval and storage conditions

    Article • Neurochemistry International, December 2010, Elsevier

    Dr Edna Grünblatt

  199. Alteration of the pro-oxidant xanthine oxidase (XO) in the thalamus and occipital cortex of patients with schizophrenia

    Article • The World Journal of Biological Psychiatry, November 2010, Taylor & Francis

    Dr Edna Grünblatt

  200. Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson’s disease

    Article • Acta Neurovegetativa, November 2010, Springer Science + Business Media

    Dr Edna Grünblatt

  201. Effects of methylphenidate: the cellular point of view

    Article • ADHD Attention Deficit and Hyperactivity Disorders, November 2010, Springer Science + Business Media

    Dr Edna Grünblatt

  202. PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease

    Article • Science Translational Medicine, October 2010, American Association for the Advancement of Science

    Dr Edna Grünblatt

  203. Methyl- and acetyltransferases are stable epigenetic markers postmortem

    Article • Cell and Tissue Banking, July 2010, Springer Science + Business Media

    Dr Edna Grünblatt

  204. The link between iron, metabolic syndrome, and Alzheimer’s disease

    Article • Acta Neurovegetativa, June 2010, Springer Science + Business Media

    Dr Edna Grünblatt

  205. Diabetes Type II: A Risk Factor for Depression–Parkinson–Alzheimer?

    Article • Neurotoxicity Research, June 2010, Springer Science + Business Media

    Dr Edna Grünblatt

  206. Increased Mitochondrial Aldehydedehydrogenase in the putamen of individuals with Alzheimer's disease

    Article • Journal of Alzheimer’s Disease, March 2010, IOS Press

    Dr Edna Grünblatt

  207. Increased xanthine oxidase in the thalamus and putamen in depression

    Article • The World Journal of Biological Psychiatry, March 2010, Taylor & Francis

    Dr Edna Grünblatt

  208. Genetics of early-onset obsessive–compulsive disorder

    Article • European Child & Adolescent Psychiatry, March 2010, Springer Science + Business Media

    Dr Edna Grünblatt

  209. Can enzyme kinetics of prooxidants teach us a lesson about the treatment of Alzheimer's disease: A pilot post-mortem study

    Article • The World Journal of Biological Psychiatry, January 2010, Taylor & Francis

    Dr Edna Grünblatt

  210. Chronic exogenous corticosterone administration generates an insulin-resistant brain state in rats

    Article • Stress, November 2009, Taylor & Francis

    Dr Edna Grünblatt

  211. Modeling Sporadic Alzheimer's Disease: The Insulin Resistant Brain State Generates Multiple Long-Term Morphobiological Abnormalities Including Hyperphosphorylated Tau Protein and Amyloid-β

    Article • Journal of Alzheimer’s Disease, November 2009, IOS Press

    Dr Edna Grünblatt

  212. Tryptophan is a marker of human postmortem brain tissue quality

    Article • Journal of Neurochemistry, September 2009, Wiley

    Dr Edna Grünblatt

  213. P.1.d.01l Multilevel phenotyping of NOS-I knockdown mice

    Article • European Neuropsychopharmacology, September 2009, Elsevier

    Dr Edna Grünblatt

  214. Stress and methylphenidate treatment, both modulate neuronal activity in an animal model for ADHD

    Article • Pharmacopsychiatry, August 2009, Thieme Publishing Group

    Dr Edna Grünblatt

  215. Potential gene expression biomarkers in whole blood of Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2009, Elsevier

    Dr Edna Grünblatt

  216. pH measurement as quality control on humanpost mortembrain tissue: a study of the BrainNet Europe consortium

    Article • Neuropathology and Applied Neurobiology, June 2009, Wiley

    Dr Edna Grünblatt

  217. Gene Expression as Peripheral Biomarkers for Sporadic Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, March 2009, IOS Press

    Dr Edna Grünblatt

  218. Genetic risk factors and markers for Alzheimer’s disease and/or depression in the VITA study

    Article • Journal of Psychiatric Research, January 2009, Elsevier

    Dr Edna Grünblatt

  219. Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers

    Article • The World Journal of Biological Psychiatry, January 2009, Taylor & Francis

    Dr Edna Grünblatt

  220. Trabalho de consenso de força-tarefa da WFSBP sobre marcadores biológicos das demências: contribuição da análise do LCR e do sangue para o diagnóstico precoce e diferencial das demências

    Article • Archives of Clinical Psychiatry (São Paulo), January 2009, FapUNIFESP (SciELO)

    Dr Edna Grünblatt

  221. Commonalities in the genetics of Alzheimer’s disease and Parkinson’s disease

    Article • Expert Review of Neurotherapeutics, December 2008, Taylor & Francis

    Dr Edna Grünblatt

  222. Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: A comparative post-mortem study

    Article • European Psychiatry, September 2008, Elsevier

    Dr Edna Grünblatt

  223. Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements

    Article • Acta Neurovegetativa, August 2008, Springer Science + Business Media

    Dr Edna Grünblatt

  224. P1-347: Biomarkers for Alzheimer's disease and depression in the Vienna Transdanube Aging (VITA) study

    Article • Alzheimer s & Dementia, July 2008, Elsevier

    Dr Edna Grünblatt

  225. Genomic aspects of sporadic Parkinson's disease

    Article • Parkinsonism & Related Disorders, July 2008, Elsevier

    Dr Edna Grünblatt

  226. Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss

    Article • Journal of Neurochemistry, June 2008, Wiley

    Dr Edna Grünblatt

  227. Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin-Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC-70

    Article • Annals of the New York Academy of Sciences, June 2008, Wiley

    Dr Edna Grünblatt

  228. Increased xanthine oxidase in the thalamus and putamen in depression

    Article • The World Journal of Biological Psychiatry, January 2008, Taylor & Francis

    Dr Edna Grünblatt

  229. Comparison Analysis of Gene Expression Patterns between Sporadic Alzheimer's and Parkinson's Disease

    Article • Journal of Alzheimer’s Disease, December 2007, IOS Press

    Dr Edna Grünblatt

  230. The effect of methylphenidate treatment on the expression of synaptic vesicle proteins in a mouse model for Attention-Deficit/Hyperactivity Disorder

    Article • Pharmacopsychiatry, September 2007, Thieme Publishing Group

    Dr Edna Grünblatt

  231. Methylphenidate effects on cell growth and maturation in neuronal stem cells

    Article • Pharmacopsychiatry, September 2007, Thieme Publishing Group

    Dr Edna Grünblatt

  232. Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, March 2007, SAGE Publications

    Dr Edna Grünblatt

  233. Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

    Article • Journal of Neurochemistry, January 2007, Wiley

    Dr Edna Grünblatt

  234. Genes and Oxidative Stress in Sporadic and Familial Parkinsonism: cDNA Microarray Studies

    Article • January 2007, Elsevier

    Dr Edna Grünblatt

  235. Gene and Protein Expression Profiling in Parkinson's Disease: Quest for Neuroprotective Drugs

    Article • January 2007, Springer Science + Business Media

    Dr Edna Grünblatt

  236. HIV Dementia: A Neurodegenerative Disorder with Viral Etiology

    Article • January 2007, Springer Science + Business Media

    Dr Edna Grünblatt

  237. 1.011 Early diagnosis for Parkinson's disease according to whole blood gene profile

    Article • Parkinsonism & Related Disorders, January 2007, Elsevier

    Dr Edna Grünblatt

  238. 1.100 Early diagnosis for Parkinson's disease according to whole blood gene profile

    Article • Parkinsonism & Related Disorders, January 2007, Elsevier

    Dr Edna Grünblatt

  239. Biostatistical analysis of gene microarrays reveals diverse expression clusters between macaque subspecies in brain SIV infection

    Article • January 2007, Springer Science + Business Media

    Dr Edna Grünblatt

  240. Association study of BDNF and CNTF polymorphism to depression in non-demented subjects of the “VITA” study

    Article • Journal of Affective Disorders, November 2006, Elsevier

    Dr Edna Grünblatt

  241. Insulin resistant brain state: behavioural, neurochemical and genetical resemblance to sporadic Alzheimer's disease

    Article • Experimental and Clinical Endocrinology & Diabetes, October 2006, Thieme Publishing Group

    Dr Edna Grünblatt

  242. Estrogen Receptor ?? Gene (ESR??) 3???-UTR Variants in Alzheimer Disease

    Article • Alzheimer Disease & Associated Disorders, October 2006, Wolters Kluwer Health

    Dr Edna Grünblatt

  243. Association Study of the 5-HTTLPR Polymorphism and Depression in 75-Year-Old Nondemented Subjects From the Vienna Transdanube Aging (VITA) Study

    Article • The Journal of Clinical Psychiatry, September 2006, Physicians Postgraduate Press, Inc

    Dr Edna Grünblatt

  244. Serotonin transporter polymorphism and LDL-cholesterol

    Article • Molecular Psychiatry, July 2006, Springer Science + Business Media

    Dr Edna Grünblatt

  245. Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat

    Article • Journal of Alzheimer’s Disease, July 2006, IOS Press

    Dr Edna Grünblatt

  246. The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice

    Article • Acta Neurovegetativa, June 2006, Springer Science + Business Media

    Dr Edna Grünblatt

  247. Microarray analysis reveals distinct gene expression patterns in the mouse cortex following chronic neuroleptic and stimulant treatment: implications for body weight changes

    Article • Acta Neurovegetativa, February 2006, Springer Science + Business Media

    Dr Edna Grünblatt

  248. Neuroprotective Strategies in Parkinson's Disease Using the Models of 6-Hydroxydopamine and MPTPa

    Article • Annals of the New York Academy of Sciences, January 2006, Wiley

    Dr Edna Grünblatt

  249. Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation

    Article • Journal of Neurochemistry, October 2005, Wiley

    Dr Edna Grünblatt

  250. Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin-Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC-70

    Article • Annals of the New York Academy of Sciences, August 2005, Wiley

    Dr Edna Grünblatt

  251. Consensus Paper of the WFSBP Task Force on Biological Markers of Dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia

    Article • The World Journal of Biological Psychiatry, May 2005, Taylor & Francis

    Dr Edna Grünblatt

  252. Oxidative stress related markers in the “VITA” and the centenarian projects

    Article • Neurobiology of Aging, April 2005, Elsevier

    Dr Edna Grünblatt

  253. Genexpressionanalysen von Substantia-nigra-Gewebe Parkinson-Kranker

    Article • Aktuelle Neurologie, March 2005, Thieme Publishing Group

    Dr Edna Grünblatt

  254. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

    Article • Acta Neurovegetativa, September 2004, Springer Science + Business Media

    Dr Edna Grünblatt

  255. Gene expression profile in streptozotocin rat model for sporadic Alzheimer?s disease

    Article • Acta Neurovegetativa, March 2004, Springer Science + Business Media

    Dr Edna Grünblatt

  256. The benefits of microarrays as tools for studying neuropsychiatric disorders

    Article • Drugs of Today, January 2004, Prous Science

    Dr Edna Grünblatt

  257. Symposia

    Article • January 2004, Springer Science + Business Media

    Dr Edna Grünblatt

  258. Monoamine Oxidase-B Inhibition in Alzheimer's Disease

    Article • NeuroToxicology, January 2004, Elsevier

    Dr Edna Grünblatt

  259. Neuroprotective Strategies in Parkinson???s Disease

    Article • CNS Drugs, January 2003, Springer Science + Business Media

    Dr Edna Grünblatt

  260. Free radicals in Parkinson's disease

    Article • Deutsche Zeitschrift für Nervenheilkunde, September 2002, Springer Science + Business Media

    Dr Edna Grünblatt

  261. Early and late molecular events in neurodegeneration and neuroprotection in Parkinson’s disease MPTP model as assessed by cDNA microarray; the role of iron

    Article • Neurotoxicity Research, January 2002, Springer Science + Business Media

    Dr Edna Grünblatt

  262. Monoamin-Oxidase-Hemmer

    Article • January 2002, Springer Science + Business Media

    Dr Edna Grünblatt

  263. Article • Neurochemical Research, January 2002, Springer Science + Business Media

    Dr Edna Grünblatt

  264. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine

    Article • Journal of Neurochemistry, December 2001, Wiley

    Dr Edna Grünblatt

  265. Molecular events in dopaminergic neurodegeneration and neuroprotection in MPTP model of Parkinson’s disease employing cDNA microarray Silvia Mandel, Edna Grünblatt, Yona Levites, Gila Maor, Moussa BH Youdim

    Article • September 2001, Taylor & Francis

    Dr Edna Grünblatt

  266. Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss

    Article • Journal of Neurochemistry, April 2001, Wiley

    Dr Edna Grünblatt

  267. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies

    Article • Deutsche Zeitschrift für Nervenheilkunde, April 2000, Springer Science + Business Media

    Dr Edna Grünblatt

  268. Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for Neuroprotection

    Article • January 2000, Springer Science + Business Media

    Dr Edna Grünblatt

  269. cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson’s disease

    Article • January 2000, Springer Science + Business Media

    Dr Edna Grünblatt

  270. Iron chelating, antioxidant and cytoprotective properties of dopamine receptor agonist; apomorphine

    Article • January 2000, Springer Science + Business Media

    Dr Edna Grünblatt

  271. The Pivotal Role of Iron in NF-kappaB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators

    Article • Annals of the New York Academy of Sciences, December 1999, Wiley

    Dr Edna Grünblatt

  272. Apomorphine protects against MPTP-induced neurotoxicity in mice

    Article • Movement Disorders, July 1999, Wiley

    Dr Edna Grünblatt

  273. Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity

    Article • January 1999, Springer Science + Business Media

    Dr Edna Grünblatt

  274. A hierarchical approach to vegetation classification in Kenya

    Article • African Journal of Ecology, March 1989, Wiley

    Dr Edna Grünblatt

  275. Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals

    Article • Springer Science + Business Media

    Dr Edna Grünblatt